2/8
10:18 pm
incy
Incyte (INCY) Q4 Earnings: What To Expect [Yahoo! Finance]
Low
Report
Incyte (INCY) Q4 Earnings: What To Expect [Yahoo! Finance]
2/6
07:07 am
incy
Incyte (NASDAQ:INCY) had its "overweight" rating reaffirmed by analysts at Piper Sandler.
Medium
Report
Incyte (NASDAQ:INCY) had its "overweight" rating reaffirmed by analysts at Piper Sandler.
2/5
04:21 pm
incy
TD Cowen Keeps Buy Rating on Incyte (INCY), Cites Roadmap to Triple Non-Jakafi Revenue by 2029 [Yahoo! Finance]
Medium
Report
TD Cowen Keeps Buy Rating on Incyte (INCY), Cites Roadmap to Triple Non-Jakafi Revenue by 2029 [Yahoo! Finance]
2/5
07:00 am
incy
Incyte (NASDAQ:INCY) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $135.00 price target on the stock.
Low
Report
Incyte (NASDAQ:INCY) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $135.00 price target on the stock.
2/4
02:58 pm
incy
Analysts Differ in Opinion on Jakafi Drug Maker Incyte (INCY) [Yahoo! Finance]
Low
Report
Analysts Differ in Opinion on Jakafi Drug Maker Incyte (INCY) [Yahoo! Finance]
2/4
06:09 am
incy
Incyte (NASDAQ:INCY) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
Low
Report
Incyte (NASDAQ:INCY) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
2/4
12:33 am
incy
How Investors Are Reacting To Incyte (INCY) EMA Boost For Zynyz In First-Line Anal Cancer [Yahoo! Finance]
Low
Report
How Investors Are Reacting To Incyte (INCY) EMA Boost For Zynyz In First-Line Anal Cancer [Yahoo! Finance]
2/3
11:42 am
incy
Prelude climbs as FDA clears study for Incyte-partnered cancer candidate [Seeking Alpha]
Low
Report
Prelude climbs as FDA clears study for Incyte-partnered cancer candidate [Seeking Alpha]
1/30
09:29 am
incy
Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)
Low
Report
Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)
1/27
08:00 am
incy
Incyte to Report Fourth Quarter and Year-End 2025 Financial Results
Low
Report
Incyte to Report Fourth Quarter and Year-End 2025 Financial Results
1/24
05:08 am
incy
Incyte (NASDAQ:INCY) had its "hold (c+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Incyte (NASDAQ:INCY) had its "hold (c+)" rating reaffirmed by analysts at
Weiss Ratings.
1/21
11:22 am
incy
Reassessing Incyte (INCY) Valuation After Wells Fargo's Neutral Downgrade [Yahoo! Finance]
Low
Report
Reassessing Incyte (INCY) Valuation After Wells Fargo's Neutral Downgrade [Yahoo! Finance]
1/21
06:19 am
incy
Incyte (NASDAQ:INCY) was downgraded by analysts at Wells Fargo & Company from a "strong-buy" rating to a "hold" rating.
Low
Report
Incyte (NASDAQ:INCY) was downgraded by analysts at Wells Fargo & Company from a "strong-buy" rating to a "hold" rating.
1/21
03:12 am
incy
LeapSpace goes live: the Research-Grade AI-Assisted Workspace built on trusted science [Yahoo! Finance]
Low
Report
LeapSpace goes live: the Research-Grade AI-Assisted Workspace built on trusted science [Yahoo! Finance]
1/20
07:17 am
incy
Incyte (NASDAQ:INCY) was given a new $107.00 price target on by analysts at Wells Fargo & Company.
Low
Report
Incyte (NASDAQ:INCY) was given a new $107.00 price target on by analysts at Wells Fargo & Company.
1/18
01:02 pm
incy
The 20 stocks hedge funds are most overweight [Seeking Alpha]
Medium
Report
The 20 stocks hedge funds are most overweight [Seeking Alpha]
1/16
01:55 pm
incy
Incyte: Buy For The Turnaround, Stay For The Pipeline [Seeking Alpha]
Low
Report
Incyte: Buy For The Turnaround, Stay For The Pipeline [Seeking Alpha]
1/16
08:26 am
incy
Incyte's Pipeline Potential Signals Massive Upside For Investors [Seeking Alpha]
Low
Report
Incyte's Pipeline Potential Signals Massive Upside For Investors [Seeking Alpha]
1/15
11:56 am
incy
Factbox-Pharma sector doubles down on AI amid hopes of slashing costs, timelines [Yahoo! Finance]
Low
Report
Factbox-Pharma sector doubles down on AI amid hopes of slashing costs, timelines [Yahoo! Finance]
1/14
08:31 pm
incy
Earnings Preview: What To Expect From Incyte's Report [Yahoo! Finance]
Low
Report
Earnings Preview: What To Expect From Incyte's Report [Yahoo! Finance]
1/14
04:41 pm
incy
Why Incyte (INCY) Stock Is Trading Up Today [Yahoo! Finance]
Low
Report
Why Incyte (INCY) Stock Is Trading Up Today [Yahoo! Finance]
1/13
05:50 pm
incy
Incyte CEO Bill Meury: Blood cancer therapy development is company's central identity [CNBC]
Low
Report
Incyte CEO Bill Meury: Blood cancer therapy development is company's central identity [CNBC]
1/13
02:27 pm
incy
Incyte (NASDAQ:INCY) had its price target raised by analysts at TD Cowen from $101.00 to $128.00. They now have a "buy" rating on the stock.
Low
Report
Incyte (NASDAQ:INCY) had its price target raised by analysts at TD Cowen from $101.00 to $128.00. They now have a "buy" rating on the stock.
1/13
09:09 am
incy
Incyte (NASDAQ:INCY) had its "buy" rating reaffirmed by analysts at Cowen Inc.
Low
Report
Incyte (NASDAQ:INCY) had its "buy" rating reaffirmed by analysts at Cowen Inc.
1/12
01:51 pm
incy
Will Incyte (INCY) Beat Estimates Again in Its Next Earnings Report? [Yahoo! Finance]
Low
Report
Will Incyte (INCY) Beat Estimates Again in Its Next Earnings Report? [Yahoo! Finance]